The other three post-treatment tumours (patients 9, 11 and 8) had either a high stromal cell density (patients 9 and 11) or consisted of a single small residual nodule (patient 8) that might have impeded detection of the TP53 mutation in these non-microdissected frozen samples. The gene discussed is TP53; the disease is neoplasm.